(Date:11/30/2009)... , , AMSTERDAM, November 30 /PRNewsw...nounces today that the first patients have been en...trial with ATIR(TM). The study is,designed to show...fter one,year following an allogeneic stem cell tr...donor in blood cancer patients eligible for an all...
(Date:11/30/2009)... , , NOVATO, Calif., Nov. 30 /PRNewswire-F... BMRN ) announced today that the Food and Drug Ad...tion for 3,4-diaminopyridine (3,4-DAP), amifamprid...bert Eaton Myasthenic Syndrome (LEMS). 3,4-DAP ha...he E.U. Also, in October 2009, the Committee for ...
(Date:11/30/2009)... , , SHANGHAI, Nov. 30 /PRNewswi...ng pharmaceutical, biotechnology, and medical-devi...th operations in China and the United States,anno...chnology Fast 50 China,2009 list for the fifth con...growing companies in China,s technology, media, an...
(Date:11/28/2009)... , The Vanuatu National A...h its Second National Communication (SNC) Project ...ervices and CLIMsystems Ltd. of New Zealand have g...rise results that will form the background for the...ns Framework Convention on Climate Change (UNFCCC)...
Breaking Biology Technology:Kiadis Pharma Announces Enrollment of First Patients in a Multinational Registration Study for ATIR(TM) 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4WuXi PharmaTech Named in Deloitte Technology Fast 50 China 2009 List for the Fifth Consecutive Year 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 2Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 3Preliminary Climate and Sea Level Changes for Vanuatu Through the Application of SimCLIM 4